Fig. 7From: mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markersSirolimus treatment reduced SASP factors A IL-6 and B TNFα staining by IHC and the quantitative expression analysis of their positive staining in pre- and post-sirolimus-treated normal (n=12) and DCIS tissues (n=6). Significance was evaluated by 2-way ANOVA. Scale bar, 100 μm. Back to article page